This company has been marked as potentially delisted and may not be actively trading. NYSE:ARPI (ARPI) (ARPI) Stock Price, News & Analysis Add Share Share Stock Analysis Stock AnalysisBuy This Stock About (ARPI) Stock (NYSE:ARPI) 30 days 90 days 365 days Advanced Chart Get (ARPI) alerts:Sign Up Key Stats Today's Range$15.89▼$15.8950-Day Range N/A52-Week Range$14.64▼$19.68VolumeN/AAverage Volume491,792 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview American Residential Properties, Inc. is an internally managed real estate investment company, which is organized as a real estate investment trust. The Company acquires, owns, renovates, and manages single-family homes as rental properties. American Residential Properties OP, L.P. acts as its operating partnership. American Residential Leasing Company, LLC is a wholly owned subsidiary of its operating partnership. The Company owns 8,893 properties in Arizona, California, Colorado, Florida, Georgia, Illinois, Indiana, Nevada, North Carolina, Ohio, South Carolina, Tennessee and Texas that were 81% leased, and it managed an additional 437 properties for ARP Phoenix Fund I, LP in Arizona and Nevada. In addition to its primary business, the Company has a private mortgage financing business. Read More Receive ARPI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (ARPI) and its competitors with MarketBeat's FREE daily newsletter. Email Address ARPI Stock News HeadlinesAI-designed inhibitor targets key enzyme to fight prostate cancer drug resistanceJuly 2 at 10:53 AM | msn.comDalai Lama alone can decide on reincarnation: French scholar ArpiJune 29, 2025 | msn.com379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsJuly 4 at 2:00 AM | True Market Insiders (Ad)XTANDI® (enzalutamide) now funded in Ontario for all approved prostate cancer indicationsJune 26, 2025 | finance.yahoo.comNovartis reports topline outcomes from trial of Pluvicto for prostate cancerJune 4, 2025 | msn.comPARP-ARPI Combo Sets New Standard for Metastatic Hormone-Sensitive Prostate CancerJune 4, 2025 | msn.comAstellas and Pfizer’s Xtandi combo reduces death risk in prostate cancer trialMay 23, 2025 | msn.comFDA approves Novartis radioligand therapy Pluvicto for earlier use in mCRPCMarch 29, 2025 | markets.businessinsider.comSee More Headlines ARPI Stock Analysis - Frequently Asked Questions How were (ARPI)'s earnings last quarter? (ARPI) (NYSE:ARPI) issued its quarterly earnings data on Wednesday, November, 4th. The real estate investment trust reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.21 by $0.07. The business's revenue was up 36.1% compared to the same quarter last year. What other stocks do shareholders of (ARPI) own? Based on aggregate information from My MarketBeat watchlists, some other companies that (ARPI) investors own include American Homes 4 Rent (AMH), Blackstone (BX), NGL Energy Partners (NGL), Kelly Residential & Apartment Real Estate ETF (RESI), (SBY) (sby), Starwood Property Trust (STWD) and Apartment Investment and Management (AIV). Company Calendar Last Earnings11/04/2015Today7/04/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNYSE:ARPI CIK1548981 Webwww.americanresidentialproperties.com Phone+1-480-4744800FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free Report This page (NYSE:ARPI) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (ARPI) Please log in to your account or sign up in order to add this asset to your watchlist. Share (ARPI) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.